Free Trial
→ URGENT: This Altcoin Opportunity Won’t Wait – Act Now (From Crypto Swap Profits) (Ad) Free LGND Stock Alerts

Ligand Pharmaceuticals (LGND) Insider Trading & Ownership

Ligand Pharmaceuticals logo
$114.64 +0.70 (+0.61%)
(As of 12/20/2024 05:16 PM ET)
Compare

Ligand Pharmaceuticals (NASDAQ:LGND) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.90%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$243,475.00
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$7.86 M
Get LGND Insider Trade Alerts

Want to know when executives and insiders are buying or selling Ligand Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

LGND Insider Buying and Selling by Quarter

Ad Crypto Swap Profits
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
>> Register for the Workshop Now

Ligand Pharmaceuticals Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/27/2024John L LamattinaDirectorSell2,406$123.65$297,501.90  
9/23/2024Andrew ReardonInsiderSell2,000$99.60$199,200.00  
9/23/2024Matthew E KorenbergCOOSell9,772$101.22$989,121.84  
9/20/2024Matthew E KorenbergCOOSell6,275$104.10$653,227.50  
9/20/2024Octavio EspinozaCFOSell1,275$103.94$132,523.50  
8/28/2024Andrew ReardonInsiderSell1,500$106.39$159,585.00  
8/26/2024Matthew E KorenbergCOOSell11,389$105.61$1,202,792.29  
8/22/2024Matthew E KorenbergCOOSell1,157$105.54$122,109.78  
8/9/2024Matthew E KorenbergCOOSell18,245$98.50$1,797,132.50  
8/8/2024Todd C DavisCEOBuy2,500$97.39$243,475.00  
5/17/2024Octavio EspinozaCFOSell5,156$86.66$446,818.96  
5/15/2024Octavio EspinozaCFOSell5,873$86.01$505,136.73  
5/13/2024Matthew E KorenbergInsiderSell3,440$84.54$290,817.60  
5/9/2024Andrew ReardonInsiderSell10,000$83.04$830,400.00  
5/9/2024Nancy Ryan GrayDirectorSell934$83.20$77,708.80  
3/5/2024Stephen L SabbaDirectorSell1,893$74.30$140,649.90  
2/28/2024Octavio EspinozaCFOSell140$88.46$12,384.40  
(Data available from 1/1/2013 forward)

LGND Insider Trading Activity - Frequently Asked Questions

The list of insiders at Ligand Pharmaceuticals includes Andrew Reardon, John L Higgins, John L Lamattina, John W Kozarich, Matthew E Korenberg, Matthew W Foehr, Nancy Ryan Gray, Octavio Espinoza, Stephen L Sabba, and Todd C Davis. Learn more on insiders at LGND.

5.90% of Ligand Pharmaceuticals stock is owned by insiders. Learn more on LGND's insider holdings.

The following insider purchased LGND shares in the last 24 months: Todd C Davis ($480,995.00).

Insiders have purchased a total of 6,500 LGND shares in the last 24 months for a total of $480,995.00 bought.

The following insiders have sold LGND shares in the last 24 months: Andrew Reardon ($1,210,161.00), John L Lamattina ($297,501.90), John W Kozarich ($833,673.28), Matthew E Korenberg ($5,055,201.51), Nancy Ryan Gray ($77,708.80), Octavio Espinoza ($1,096,863.59), and Stephen L Sabba ($634,898.94).

Insiders have sold a total of 99,015 Ligand Pharmaceuticals shares in the last 24 months for a total of $9,206,009.02 sold.

Ligand Pharmaceuticals Key Executives

  • Mr. Matthew E. Korenberg (Age 49)
    President & COO
    Compensation: $831.77k
    5 recent trades
  • Mr. Octavio Espinoza (Age 53)
    Chief Financial Officer
    Compensation: $613.59k
    1 recent trades
  • Mr. Andrew T. Reardon J.D. (Age 49)
    Chief Legal Officer & Secretary
    Compensation: $614.87k
  • Mr. Scott M. Plesha (Age 59)
    Chief Executive Officer
  • Mr. Paul J. Hadden
    Senior Vice President of Investments & Business Development
  • Simon Latimer
    Head of Investor Relations
  • Mr. Todd Pettingill
    Director of Corporate Development
  • Ms. Audrey Warfield-Graham
    Chief People Officer
  • Dr. Keith Marschke
    Senior Vice President of Biology & Scientific Affairs
  • Dr. Vincent D. Antle (Age 55)
    Senior Vice President of Technical Operations & QA - Capitsol

Related Companies
Insider Tracking Tools
Insider Trading By Country
Latest Articles

This page (NASDAQ:LGND) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners
Amazon coin set to soar 25X – starting December 16th?
This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...
True Market Insiders | Sponsored
Did You See Trump’s Bombshell Exec. Order 001?
Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."
Banyan Hill Publishing | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
The #1 Crypto for AI
We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...
Weiss Ratings | Sponsored
24/7 Automated Profits in Crypto
What if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...
Crypto Swap Profits | Sponsored
Elon Musk’s chilling warning for humanity
The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...
The Freeport Society | Sponsored
Trump’s Sending THIS Crypto Higher on Purpose
Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…
Crypto 101 Media | Sponsored
Vladimir Lenin was right…
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...
Porter & Company | Sponsored